Evidence map›Paper›PMID 14623913›Full record

ArticleThe Journal of experimental medicine2003

Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.

Keiko Fujikawa, Ana V Miletic, Frederick W Alt, Roberta Faccio, Tracie Brown, Jeremy Hoog, Jessica Fredericks, Shinzo Nishi, Shirly Mildiner, Sheri L Moores and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it, 222 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. RAC1 signaling in prostate cancer: VAV GEFs take center stage.Frontiers in cell and developmental biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. GPCRs thatSmall GTPases · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. ImmunoHorizons · 2020
    Article
  18. International journal of environmental research and public health · 2020
    Article
  19. Vav2 lacks CaJournal of cell science · 2020
    Article
  20. Review

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Keiko Fujikawa660 S. Euclid Ave., Dept. of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Ana V Miletic
Frederick W Alt
Roberta Faccio
Tracie Brown
Jeremy Hoog
Jessica Fredericks
Shinzo Nishi
Shirly Mildiner
Sheri L Moores
Joan Brugge
Fred S Rosen
Wojciech Swat
Washington University in St. Louis · USHarvard University · USHokkaido University · JPHoward Hughes Medical Institute · US

Funding

WIP in TCR signaling and actin reorganizationP01HL059561 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI GEHA, RAIF SALIM · 1997 to 2012
$21.8M
SIGNAL TRANSDUCTION EVENTS REGULATED BY INTEGRINSR01CA078773 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BRUGGE, JOAN SIEFERT · 1998 to 2003
$1.7M
NCI NIH HHS CA78773NCI NIH HHS R01 CA078773NHLBI NIH HHS HL059561NHLBI NIH HHS P01 HL059561
6 · The paper itself

Abstract

The Vav family of Rho guanine nucleotide exchange factors is thought to orchestrate signaling events downstream of lymphocyte antigen receptors. Elucidation of Vav function has been obscured thus far by the expression of three highly related family members. We generated mice lacking all Vav family proteins and show that Vav-null mice produce no functional T or B cells and completely fail to mount both T-dependent and T-independent humoral responses. Whereas T cell development is blocked at an early stage in the thymus, immature B lineage cells accumulate in the periphery but arrest at a late "transitional" stage. Mechanistically, we show that the Vav family is crucial for both TCR and B cell receptor (BCR)-induced Ca2+ signaling and, surprisingly, is only required for mitogen-activated protein kinase (MAPK) activation in developing and mature T cells but not in B cells. Thus, the abundance of immature B cells generated in Vav-null mice may be due to intact Ras/MAPK signaling in this lineage. Although the expression of Vav1 alone is sufficient for normal lymphocyte development, our data also reveal lineage-specific roles for Vav2 and Vav3, with the first demonstration that Vav3 plays a critical compensatory function in T cells. Together, we define an essential role for the entire Vav protein family in lymphocyte development and activation and establish the limits of functional redundancy both within this family and between Vav and other Rho-guanine nucleotide exchange factors.

Indexed as

Cell Cycle ProteinsAnimalsB-LymphocytesCalciumCalcium SignalingCell DifferentiationGuanine Nucleotide Exchange FactorsMiceMitogen-Activated Protein KinasesOncogene ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-vavSignal TransductionT-LymphocytesCalciumCell Cycle ProteinsGuanine Nucleotide Exchange FactorsMitogen-Activated Protein KinasesOncogene ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-vavVav1 protein, mouseVav2 protein, mouseVav3 protein, mouse

Identifiers

PMID14623913
PMCPMC2194126
OpenAlexW2153014356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.